noscript

News and Announcements

Proteomics International Receives FY16 R&D Tax Incentive

  • Published September 23, 2016 11:51AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

21st September 2016, ASX Announcement

Innovative biomarker research conducted by Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has been boosted by the receipt of more than half a million dollars in research and development tax incentive for the 2015-16 financial year.

PILL’s sustainable business model sees the company use revenue generated from analytical services to fun pioneering research into next generation diagnostic tests and drug delivery.

This self-sustaining model adopted blue sky concepts with cash flow from day one, using revenue from services to cover operational costs and drive substantial investment in R&D.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now